L.B. Bohle total revenue increases to more than EUR 50 million in 2017

Tim Remmert and Thorsten Wesselmann of L.B. Bohle discuss business decisions which lead to an increase in total revenue in 2017

picture of

Breaking News

Relocation reflects ambitious growth plans

Ingenza is pleased to announce its relocation to Roslin Innovation Centre, a 30 million, multipurpose research hub on ...

Advent International to acquire Zentiva, Sanofi's European generics business

Advent to invest in Zentiva to create a new, independent European generics leader

Samdi Tech expands small molecule compound libraries through partnership with Enamine

SAMDI Tech, Inc., headquartered in Chicago (IL, USA) leads the industry with an innovative approach to drug discovery

Should robots pay taxes?

Robot tax? A tax on robotics is as absurd an idea as a tax on pencils

Wacker strengthens its pharmaceutical-protein business and buys Dutch biotech plant

Wacker Chemie AG has acquired a Dutch site to manufacture biopharmaceuticals, live microbial products and vaccines, ...

Crescendo Biologics reaches first major milestone in strategic collaboration with Takeda

Crescendo, the developer of multifunctional biologics, including targeted T-cell engagers, has achieved the first major ...

A look back at 2017 healthcare transactions

Last year, 2017, saw 2011 deals complete, with Q2 showing the strongest performance with 29.4%, followed by Q1 with 27. ...

Almac Group expands US specialised commercial packaging capabilities

Almac Group, the global contract pharmaceutical development and manufacturing organisation, is pleased to announce that ...

Sartorius Stedim Biotech and Penn State University announce partnership

Sartorius Stedim Biotech and Penn State University have entered into a collaborative partnership to advance ...

Slow and steady

Generic drugs find a growing position in the US pharma market

When renting might be the better option

Capital expenditure and investment in a water infrastructure are critical to maintaining an ongoing high quality ...

Chinese pharma regulatory reforms will help to attract foreign investment

China is the second largest pharmaceutical market in the world

Shire announces sale of oncology business to Servier for $2.4 billion

Oncology business provides Servier with an immediate presence in the US, enhancing its commitment to addressing unmet ...